Outcomes of lung cancers manifesting as nonsolid nodules

Lung Cancer

Volumn 97, Issue , 2016, Pages 35-42

  Yip, Rowena ^a   Wolf, Andrea ^a   Tam, Kathleen ^a   Taioli, Emanuela ^a   Olkin, Ingram ^b   Flores, Raja M ^a   Yankelevitz, David F ^a   Henschke, Claudia I ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

Lung neoplasm; Screening; Surgery; Surveillance; Survival

Indexed keywords

CANCER STAGING; CLINICAL FEATURE; HUMAN; LUNG ADENOCARCINOMA; LUNG CANCER; LUNG NODULE; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRIORITY JOURNAL; REVIEW; SURVIVAL RATE; ADENOCARCINOMA; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; LUNG NEOPLASMS; MALE; MASS SCREENING; MORTALITY; MULTIPLE PULMONARY NODULES; PATHOLOGY; PROCEDURES; X-RAY COMPUTED TOMOGRAPHY;

ADENOCARCINOMA; FEMALE; FOLLOW-UP STUDIES; HUMANS; LUNG NEOPLASMS; MALE; MASS SCREENING; MULTIPLE PULMONARY NODULES; OUTCOME ASSESSMENT (HEALTH CARE); SURVIVAL RATE; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84964422537     PISSN: 01695002     EISSN: 18728332     Source Type: Journal    
DOI: 10.1016/j.lungcan.2016.04.005     Document Type: Review

References (63)

1. Yankelevitz D., Yip R., Smith J.P., Liang M., Liu Y., Xu D.M., et al. CT screening for lung cancer: nonsolid nodules in baseline and annual repeat rounds. Radiology 2015, 277:555-564. 10.1148/radiol.2015142554.
2. Asamura H., Suzuki K., Watanabe S., Matsuno Y., Maeshima A., Tsuchiya R. A clinicopathological study of resected subcentimeter lung cancers: a favorable prognosis for ground glass opacity lesions. Ann. Thorac. Surg. 2003, 76:1016-1022.
3. Sone S., Nakayama T., Honda T., Tsushima K., Li F., Haniuda M., et al. Long-term follow-up study of a population-based 1996-1998 mass screening programme for lung cancer using mobile low-dose spiral computed tomography. Lung Cancer 2007, 58(December):329-341.
4. Vazquez D., Carter E., Brambilla A., Gazdar M., et al. Solitary and multiple resected adenocarcinomas after CT screening for lung cancer: histopathologic features and their prognostic implications. Lung Cancer 2009, 64(May):148-154.
5. Noguchi A., Morikawa M., Kawasaki Y., Matsuno T., et al. Small adenocarcinoma of the lung. Histologic characteristics and prognosis. Cancer 1995, 75(June):2844-2852.
6. Kakinuma H., Ohmatsu M., Kaneko M., Kusumoto J., et al. Progression of focal pure ground-glass opacity detected by low-dose helical computed tomography screening for lung cancer. J. Comput. Assist. Tomogr. 2004, 28(January-February):17-23.
7. Chang B.H., Choi J.H., Chung Y.H., Kim M.P., Kwon H., Lee O.J., Lee H.Y., Shim K.S., Han Y.M., Um J., SW Natural history of pure ground-glass opacity lung nodules detected by low-dose CT scan. Chest 2013, 143(January):172-178.
8. Moyer V.A., U.S.Preventive Services Task Force Screening for lung cancer: U.S. preventive services task force recommendation statement. Ann. Intern. Med. 2014, 160(March (4)):330-338.
9. CMM Services, Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N), T. C. f. Medicare and S. Medicaid, Eds., ed, 2014.
10. Travis E., Brambilla M., Nicholson A.G., Geisinger K.R., Yatabe Y., et al. International association for the study of lung cancer/american thoracic society/european respiratory society international multidisciplinary classification of lung adenocarcinoma. J. Thorac. Oncol. 2011, 6(February):244-285.
11. Goldstraw J., Crowley K., Giroux D.J., Groome P.A., Rami-Porta R., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the TNM stage groupings in the forthcoming (seventh) edition of the TNM Classification of malignant tumours. J. Thorac. Oncol. 2007, 2(August):706-714.
12. Lee H.J., Lee C.H., Jeong Y.J., Chung D.H., Goo J.M., Park C.M., et al. IASLC/ATS/ERS international multidisciplinary classification of lung adenocarcinoma: novel concepts and radiologic implications. J. Thorac. Imaging 2012, 27(November):340-353.
13. Godoy M.C., Truong M.T., Sabloff B., Naidich D.P. Subsolid pulmonary nodule management and lung adenocarcinoma classification: state of the art and future trends. Semin. Roentgenol. 2013, 48(October):295-307.
14. Good P.I. Resampling Methods: A Practical Guide to Data Analysis 2006, Birkhauser, Boston. 3rd.
15. Kodama K., Higashiyama M., Yokouchi H., Takami K., Kuriyama K., Kusunoki Y., et al. Natural history of pure ground-glass opacity after long-term follow-up of more than 2 years. Ann. Thorac. Surg. 2002, 73(February):386-392. discussion 392-3.
16. Watanabe S., Watanabe T., Arai K., Kasai T., Haratake J., Urayama H. Results of wedge resection for focal bronchioloalveolar carcinoma showing pure ground-glass attenuation on computed tomography. Ann. Thorac. Surg. 2002, 73(April):1071-1075.
17. Kishi S., Homma A., Kurosaki N., Motoi T., et al. Small lung tumors with the size of 1 cm or less in diameter: clinical, radiological, and histopathological characteristics. Lung Cancer 2004, 44(April):43-51.
18. Nakamura H., Saji H., Ogata A., Saijo T., Okada S., Kato H. Lung cancer patients showing pure ground-glass opacity on computed tomography are good candidates for wedge resection. Lung Cancer 2004, 44:61-68.
19. Nakata M., Sawada S., Yamashita M., Saeki H., Kurita A., Takashima S., et al. Surgical treatments for multiple primary adenocarcinoma of the lung. Ann. Thorac. Surg. 2004, 78:1194-1199.
20. Ohta Y., Shimizu T., Kobayashi O., Matsui H., et al. Pathologic and biological assessment of lung tumors showing ground-glass opacity. Ann. Thorac. Surg. 2006, 81(April):1194-1197.
21. Ohtsuka T., Watanabe K., Kaji M., Naruke T., Suemasu K. A clinicopathological study of resected pulmonary nodules with focal pure ground-glass opacity. Eur. J. Cardiothorac. Surg. 2006, 30(July):160-163.
22. Suzuki K., Kusumoto M., Watanabe S., Tsuchiya R., Asamura H. Radiologic classification of small adenocarcinoma of the lung: radiologic-pathologic correlation and its prognostic impact. Ann. Thorac. Surg. 2006, 81:413-419.
23. Seki N., Sawada S., Nakata M., Inoue T., Nishimura R., Segawa Y., et al. Lung cancer with localized ground-glass attenuation represents early-stage adenocarcinoma in nonsmokers. J. Thorac. Oncol. 2008, 3:483-490.
24. Park J.H., Lee K.S., Kim J.H., Shim Y.M., Kim J., Choi Y.S., et al. Malignant pure pulmonary ground-glass opacity nodules: prognostic implications. Korean J. Radiol. 2009, 10(January-February):12-20.
25. Sagawa M., Higashi K., Usuda K., Aikawa H., Machida Y., Tanaka M., et al. Curative wedge resection for non-invasive bronchioloalveolar carcinoma. Tohoku J. Exp. Med. 2009, 217:133-137.
26. Tao X., Zhao X., Pan T., Hong J. Clinical analysis of nodular ground-glass opacity appearance of lung cancer on computerized tomography (CT). Afr. J. Pharm. Pharmacol. 2011, 5:2046-2049.
27. Cho S., Yang H., Kim K., Jheon S. Pathology and prognosis of persistent stable pure ground-glass opacity nodules after surgical resection. Ann. Thorac. Surg. 2013, 96(October):1190-1195.
28. Lim H.J., Ahn S., Lee K.S., Han J., Shim Y.M., Woo S., et al. Persistent pure ground-glass opacity lung nodules >/=10mm in diameter at CT scan: histopathologic comparisons and prognostic implications. Chest 2013, 144:1291-1299.
29. Matsuguma K., Mori R., Nakahara H., Suzuki T., et al. Characteristics of subsolid pulmonary nodules showing growth during follow-up with CT scanning. Chest 2013, 143(Febuary (1)):436-443.
30. Ichinose J., Kohno T., Fujimori S., Harano T., Suzuki S., Fujii T. Invasiveness and malignant potential of pulmonary lesions presenting as pure ground-glass opacities. Ann. Thorac. Cardiovasc. Surg. 2014, 20:347-352.
31. Sim H.J., Choi S.H., Chae E.J., Kim H.R., Kim Y.H., Kim D.K., et al. Surgical management of pulmonary adenocarcinoma presenting as a pure ground-glass nodule. Eur. J. Cardiothorac. Surg. 2014, 46(October):632-636. discussion 636.
32. Ye B., Cheng M., Li W., Ge X.X., Geng J.F., Feng J., et al. Predictive factors for lymph node metastasis in clinical stage IA lung adenocarcinoma. Ann. Thorac. Surg. 2014, 98(July):217-223.
33. Sakurai K., Watanabe S.I., Asamura H. Clinicopathologic features of resected subcentimeter lung cancer. Ann. Thorac. Surg. 2015, 27(Mar).
34. Lederlin M., Puderbach T., Schnabel A., Kauczor H.U., et al. Correlation of radio- and histomorphological pattern of pulmonary adenocarcinoma. Eur. Respir. J. 2013, 41(April):943-951.
35. Matsuguma I., Oki R., Nakahara H., Suzuki T., et al. Comparison of three measurements on computed tomography for the prediction of less invasiveness in patients with clinical stage I non-small cell lung cancer. Ann. Thorac. Surg. 2013, 95(January):1878-1884.
36. Henschke C.I., Yankelevitz D.F., Miettinen O.S. Computed tomographic screening for lung cancer: the relationship of disease stage to tumor size. Arch. Intern. Med. 2006, 166:321-325.
37. Henschke C.I., Shaham D., Yankelevitz D.F., Kramer A., Kostis W.J., Reeves A.P., et al. CT screening for lung cancer: significance of diagnoses in its baseline cycle. Clin. Imaging 2006, 30:11-15.
38. Roberts D., Paul M., McGregor G., Chung T., et al. Lung cancer screening with low-dose computed tomography: canadian experience. Can. Assoc. Radiol. J. 2007, 58(October):225-235.
39. Lee, Dection of early lung cancer in patient with ground-glass opacity (GGO) lung lesion by HRCT in Taiwan, European Respiratory Journal. Conference: European Respiratory Society Annual Congress 2013 Barcelona Spain. Conference Start: 20130907Conference End: 20130911. Conference Publication: (var.pagings). 42, 2013. Date of Publication: 01 Sep 2013.
40. Nakata M., Sawada S., Saeki H., Takashima S., Mogami H., Teramoto N., et al. Prospective study of thoracoscopic limited resection for ground-glass opacity selected by computed tomography. Ann. Thorac. Surg. 2003, 75(May):1601-1605. discussion 1605-6.
41. Suzuki K., Asamura H., Kusumoto M., Kondo H., Tsuchiya R. Early peripheral lung cancer: prognostic significance of ground glass opacity on thin-section computed tomographic scan. Ann. Thorac. Surg. 2002, 74(November):1635-1639.
42. Shimada H., Saji K., Otani S., Maehara J., et al. Survival of a surgical series of lung cancer patients with synchronous multiple ground-glass opacities, and the management of their residual lesions. Lung Cancer 2015, 88(May):174-180.
43. Shiono S., Yanagawa N., Abiko M., Sato T. Detection of non-aggressive stage IA lung cancer using chest computed tomography and positron emission tomography/computed tomography. Interact. Cardiovasc. Thorac. Surg. 2014, 19:637-643.
44. Yoshida K., Nagai T., Yokose M., Nishimura R., et al. Limited resection trial for pulmonary ground-glass opacity nodules: fifty-case experience. J. Thorac. Cardiovasc. Surg. 2005, 129:991-996. ed United States.
45. Cho J.H., Choi Y.S., Kim J., Kim H.K., Zo J.I., Shim Y.M. Long-term outcomes of wedge resection for pulmonary ground-glass opacity nodules. Ann. Thorac. Surg. 2015, 99(January):218-222.
46. Yoshida G., Ishii T., Hishida K., Aokage M., et al. Limited resection trial for pulmonary ground-glass opacity nodules: case selection based on high-resolution computed tomography-interim results. Jpn. J. Clin. Oncol. 2015, 45(July):677-681.
47. Gulati C.M., Schreiner A.M., Libby D.M., Port J.L., Altorki N.K., Gelbman B.D. Outcomes of unresected ground-glass nodules with cytology suspicious for adenocarcinoma. J. Thorac. Oncol. 2014, 9:685-691. ed. United States.
48. Detterbeck F.C., Homer R.J. Approach to the ground-glass nodule. Clin. Chest Med. 2011, 32(December):799-810.
49. M. Yamaguchi, E., Inamasu, G., Toyokawa, T., Yoshida, Y., Shiraishi, F. Hirai, et al. Radiological-pathological correlation for resected small lung nodules with pure ground glass opacity detected by high-resolution computed tomography, Journal of Thoracic Oncology. Conference: 15th World Conference on Lung Cancer Sydney, NSW Australia. Conference Start: 20131027Conference End: 20131030. Conference Publication: (var.pagings). 8 (pp S811), 2013. Date of Publication: November 2013., 2013.
50. Naidich D.P., Bankier H., Schaefer-Prokop M., Goo J.M., et al. Recommendations for the management of subsolid pulmonary nodules detected at CT: a statement from the Fleischner Society. Radiology 2013, 266(January):304-317.
51. (?). (March 27, 2015, June 4). International Early Lung Cancer Action Program Protocol. Available: . http://www.ielcap.org/sites/default/files/I-ELCAP%20protocol-v21-3-1-14.pdf.
52. Kazerooni J., Austin W., Black D., Dyer T., et al. ACR-STR practice parameter for the performance and reporting of lung cancer screening thoracic computed tomography (CT): 2014 (Resolution 4). J. Thorac. Imaging 2014, 29:310-316.
53. Callister M.E., Baldwin D.R., Akram S., Barnard P., Draffan J., et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax 2015, 70(August Suppl. 2):ii1-ii54.
54. Soda Y., Nakamura K., Nakatomi N., Tomonaga H., et al. Stepwise progression from ground-glass opacity towards invasive adenocarcinoma: long-term follow-up of radiological findings. Lung Cancer 2008, 60(May):298-301.
55. Aoki H., Nakata H., Watanabe K., Nakamura T., et al. Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time. Am. J. Roentgenol. 2000, 174(March):763-768.
56. Matsuguma H., Nakahara R., Anraku M., Kondo T., Tsuura Y., Kamiyama Y., et al. Objective definition and measurement method of ground-glass opacity for planning limited resection in patients with clinical stage IA adenocarcinoma of the lung. Eur. J. Cardiothorac. Surg. 2004, 25:1102-1106.
57. Mimae Y., Miyata Y., Tsutani T., Mimura H., et al. What are the radiologic findings predictive of indolent lung adenocarcinoma?. Jpn. J. Clin. Oncol. 2015, 45:367-372.
58. Kobayashi Y., Deshpande T., Fukui T., Kuroda H., et al. The association between baseline clinical-radiological characteristics and growth of pulmonary nodules with ground-glass opacity. Lung Cancer 2014, 83(January):61-66.
59. Okada W., Nishio T., Sakamoto K., Uchino K., et al. Correlation between computed tomographic findings, bronchioloalveolar carcinoma component, and biologic behavior of small-sized lung adenocarcinomas. J. Thorac. Cardiovasc. Surg. 2004, 127:857-861.
60. Kakinuma Y., Muramatsu M., Kusumoto T., Tsuchida K., et al. Solitary pure ground-Glass nodules 5 mm or smaller: frequency of growth. Radiology 2015, (April):141071.
61. Min J.H., Lee H.Y., Lee J., Han K., Ahn M.J., et al. Stepwise evolution from a focal pure pulmonary ground-glass opacity nodule into an invasive lung adenocarcinoma: an observation for more than 10 years. Lung Cancer 2010, 69(July):123-126.
62. Hasegawa M., Sone S., Takashima S., Li F., Yang Z.G., Maruyama Y., et al. Growth rate of small lung cancers detected on mass CT screening. Br. J. Radiol. 2000, 73(December):1252-1259.
63. R. Yip, A., Jirapatnakul, M., Hu, D. M. Xu, C. I. Henschke, and D. F. Yankelevitz, Lung Cancer Deaths in the NLST Attributed to Nonsolid Nodules, presented at the 16th World Conference on Lung Cancer. International Association for the Study of Lung Cancer., Denver, Colorado, USA, 2015.